Skip to main content

Canasa

Generic: Mesalamine

Verified·Oct 26, 2026
Manufacturer
Allergan
NDC
58914-501
RxCUI
248420
Route
RECTAL
ICD-10 indication
K51.2

Affordability Check

How much will you actually pay for Canasa?

In 30 seconds, see every legitimate way to afford Canasa — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Canasa

What is this medication? Canasa is a prescription medication that contains the active ingredient mesalamine and is primarily used to treat mild to moderate ulcerative proctitis. This condition is a specific form of inflammatory bowel disease that involves inflammation and irritation in the lining of the rectum. Because it is provided as a rectal suppository, the medication works directly at the site of the inflammation to help relieve symptoms such as rectal bleeding, pain, and the frequent urge to have a bowel movement.

The drug belongs to a class of medications known as aminosalicylates, which are designed to reduce swelling and tissue damage in the digestive tract. It is typically prescribed to be used once daily at bedtime, allowing the medication to remain in the rectum for several hours to achieve maximum effectiveness. By controlling the underlying inflammation, this treatment helps patients manage their flare-ups and work toward maintaining remission of their symptoms.

Copay & patient assistance

  • Patient Copay Amount: $0 (Medicine is provided at no cost)
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Must live in the United States and be treated by a licensed U.S. healthcare provider on an outpatient basis; must have limited or no health insurance coverage; must demonstrate qualifying financial need; patients with commercial insurance requiring application to myAbbVie Assist as a condition of coverage (alternate funding programs) are ineligible; Medicare Part D patients under 150% Federal Poverty Level must provide proof of denial from the Medicare Extra Help/Low Income Subsidy (LIS) program.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Canasa appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

0%

2 of 5,499 plans

Most common tier

Tier 1

On 100% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)1
100%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 1 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.